31 Mar 2023
Assets4.06
Total Income3.07
EBITDA0.59
Profit After Tax0.28
NET Worth0.26
Reserves and Surplus-0.10
Total Borrowing1.97
Open 28th Jan 2026 · Close 30th Jan 2026 · Listing 4th Feb 2026
The shares listed at ₹191.00, a 48.06% move from the issue price. Accretion Nutraveda is a SME IPO with an issue size of ₹24.77 crore, proposed for listing on BSE SME. The offer opens on 28th Jan 2026 and closes on 30th Jan 2026. The issue structure includes a fresh issue of ₹23.53 crore. The current listing schedule points to 4th Feb 2026.
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 2000 | ₹258,000 |
| Object | Amount |
|---|---|
| Purchase of Machineries for Automation in existing Manufacturing unit | ₹4.22 Cr |
| Purchase of Machineries for New Manufacturing Setup | ₹8.03 Cr |
| Funding working capital requirements of the Company | ₹5.50 Cr |
| General Corporate Purposes | ₹3.69 Cr |
| Issue Expenses | ₹3.33 Cr |
| Total | ₹24.77 Cr |
| KPI | Mar 31, 2025 | Sep 30, 2025 |
|---|---|---|
| ROE | 81.22% | 68.54% |
| ROCE | 36.98% | 49.09% |
| Debt / Equity | 0.72% | 0.54% |
| RoNW | 48.85% | 56.50% |
| PAT Margin | 16.33% | 16.59% |
| EBITDA Margin | 22.79% | 23.36% |
| Price to Book Value | 8.76 | 7.71 |
| Expense | Amount |
|---|---|
| Purchase of Machineries for Automation in existing Manufacturing unit | ₹4.22 Cr |
| Purchase of Machineries for New Manufacturing Setup | ₹8.03 Cr |
| Funding working capital requirements of the Company | ₹5.50 Cr |
| General Corporate Purposes | ₹3.69 Cr |
| Issue Expenses | ₹3.33 Cr |
| Total | ₹24.77 Cr |